228 related articles for article (PubMed ID: 10357841)
21. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse.
Lindhorst E; Young D; Bagshaw W; Hyland M; Kisilevsky R
Biochim Biophys Acta; 1997 Apr; 1339(1):143-54. PubMed ID: 9165109
[TBL] [Abstract][Full Text] [Related]
22. Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner.
Abe-Dohmae S; Kato KH; Kumon Y; Hu W; Ishigami H; Iwamoto N; Okazaki M; Wu CA; Tsujita M; Ueda K; Yokoyama S
J Lipid Res; 2006 Jul; 47(7):1542-50. PubMed ID: 16607034
[TBL] [Abstract][Full Text] [Related]
23. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction.
Clifton PM; Mackinnon AM; Barter PJ
J Lipid Res; 1985 Dec; 26(12):1389-98. PubMed ID: 4086942
[TBL] [Abstract][Full Text] [Related]
24. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease.
Cabana VG; Gidding SS; Getz GS; Chapman J; Shulman ST
Pediatr Res; 1997 Nov; 42(5):651-5. PubMed ID: 9357939
[TBL] [Abstract][Full Text] [Related]
25. [Effects of Chinese herbal medicine Guanxinkang on lipid metabolism and serum C-reactive protein, amyloid A protein and fibrinogen in apolipoprotein E-knockout mice with atherosclerosis].
Mao MJ; Hu JP; Chen FR; Zhang YY; Liu P
Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):306-12. PubMed ID: 21419084
[TBL] [Abstract][Full Text] [Related]
26. The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease.
Wang DX; Liu H; Yan LR; Zhang YP; Guan XY; Xu ZM; Jia YH; Li YS
Chin Med J (Engl); 2013; 126(19):3656-61. PubMed ID: 24112159
[TBL] [Abstract][Full Text] [Related]
27. Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.
Rached F; Santos RD; Camont L; Miname MH; Lhomme M; Dauteuille C; Lecocq S; Serrano CV; Chapman MJ; Kontush A
J Lipid Res; 2014 Dec; 55(12):2509-20. PubMed ID: 25341944
[TBL] [Abstract][Full Text] [Related]
28. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.
Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM
J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429
[TBL] [Abstract][Full Text] [Related]
29. Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo.
Hu W; Abe-Dohmae S; Tsujita M; Iwamoto N; Ogikubo O; Otsuka T; Kumon Y; Yokoyama S
J Lipid Res; 2008 Feb; 49(2):386-93. PubMed ID: 18033752
[TBL] [Abstract][Full Text] [Related]
30. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
[TBL] [Abstract][Full Text] [Related]
31. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
[TBL] [Abstract][Full Text] [Related]
32. Marked Changes in Serum Amyloid A Distribution and High-Density Lipoprotein Structure during Acute Inflammation.
Shimano S; Ohkawa R; Nambu M; Sasaoka M; Yamazaki A; Fujii Y; Horiuchi Y; Lai SJ; Kameda T; Ichimura N; Fujita K; Tohda S; Tozuka M
Biomed Res Int; 2021; 2021():9241259. PubMed ID: 33575357
[TBL] [Abstract][Full Text] [Related]
33. Ezetimibe decreases serum amyloid A levels in HDL3 in hemodialysis patients.
Hirano T; Nohtomi K; Nakanishi N; Watanabe T; Hyodo T; Taira T
Clin Nephrol; 2010 Oct; 74(4):282-7. PubMed ID: 20875380
[TBL] [Abstract][Full Text] [Related]
34. Serum Amyloid A Is an Exchangeable Apolipoprotein.
Wilson PG; Thompson JC; Shridas P; McNamara PJ; de Beer MC; de Beer FC; Webb NR; Tannock LR
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1890-1900. PubMed ID: 29976766
[TBL] [Abstract][Full Text] [Related]
35. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice.
Reardon CA; Kan HY; Cabana V; Blachowicz L; Lukens JR; Wu Q; Liadaki K; Getz GS; Zannis VI
Biochemistry; 2001 Nov; 40(45):13670-80. PubMed ID: 11695916
[TBL] [Abstract][Full Text] [Related]
36. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.
Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ
Biochim Biophys Acta; 2012 Mar; 1821(3):502-12. PubMed ID: 21944998
[TBL] [Abstract][Full Text] [Related]
37. Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.
Jayaraman S; Haupt C; Gursky O
J Lipid Res; 2015 Aug; 56(8):1531-42. PubMed ID: 26022803
[TBL] [Abstract][Full Text] [Related]
38. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.
Marsche G; Frank S; Raynes JG; Kozarsky KF; Sattler W; Malle E
Biochem J; 2007 Feb; 402(1):117-24. PubMed ID: 17034364
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.
Melchior GW; Castle CK; Murray RW; Blake WL; Dinh DM; Marotti KR
J Biol Chem; 1994 Mar; 269(11):8044-51. PubMed ID: 8132527
[TBL] [Abstract][Full Text] [Related]
40. Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA.
Jayaraman S; Haupt C; Gursky O
J Lipid Res; 2016 Dec; 57(12):2138-2149. PubMed ID: 27744369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
